MISSION BIOCAPITAL
Mission BioCapital is a life science venture capital firm that invests in early-stage companies. The company leadership team has a long history together, investing in and launching dozens of early-stage life science companies. They are located in regions with a rich concentration of research, discovery, and venture capital investment, and they are known by leaders of portfolio companies for the expertise and deep support they provide.
MISSION BIOCAPITAL
Industry:
Life Science Medical Venture Capital
Founded:
2009-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-14 | Dren Bio | Mission BioCapital investment in Series B - Dren Bio | 65 M USD |
| 2022-06-07 | ImmunOs Therapeutics | Mission BioCapital investment in Series B - ImmunOs Therapeutics | 71 M CHF |
| 2022-05-11 | Nuvig Therapeutics | Mission BioCapital investment in Series A - Nuvig Therapeutics | 47 M USD |
| 2022-02-10 | Arkuda Therapeutics | Mission BioCapital investment in Series B - Arkuda Therapeutics | 64 M USD |
| 2022-01-06 | AmbAgon Therapeutics | Mission BioCapital investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-12-02 | Tune Therapeutics | Mission BioCapital investment in Series A - Tune Therapeutics | 40 M USD |
| 2021-10-05 | GraphWear Technologies | Mission BioCapital investment in Series B - GraphWear Technologies | 20.5 M USD |
| 2021-09-01 | Asher Bio | Mission BioCapital investment in Series B - Asher Bio | 108 M USD |
| 2021-07-15 | Shape Therapeutics | Mission BioCapital investment in Series B - Shape Therapeutics | 112 M USD |
| 2021-06-23 | Glycomine | Mission BioCapital investment in Series B - Glycomine | 35 M USD |